These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases. Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384 [TBL] [Abstract][Full Text] [Related]
6. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134 [TBL] [Abstract][Full Text] [Related]
7. A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children. Zhang M; Yu Y; Guan X; Yao X; Jia C; Hong E; Guo Y; He L Pathol Res Pract; 2022 Feb; 230():153754. PubMed ID: 34990868 [TBL] [Abstract][Full Text] [Related]
8. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887 [TBL] [Abstract][Full Text] [Related]
9. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features. Warmke LM; Meis JM Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431 [TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature. Tsuda Y; Dickson BC; Dry SM; Federman N; Suurmeijer AJH; Swanson D; Sung YS; Zhang L; Healey JH; Antonescu CR Genes Chromosomes Cancer; 2020 Apr; 59(4):217-224. PubMed ID: 31675134 [TBL] [Abstract][Full Text] [Related]
12. Sclerosing Epithelioid Fibrosarcoma of the Bone With Rare EWSR1-CREB3L3 Translocation Driving Upregulation of the PI3K/mTOR Signaling Pathway. Shenoy A; Surrey L; Jain P; Foster J; Straka J; Resnick A; Waanders A; Luo M; Li M; Kazahaya K; Bagatell R; Wojcik J; Pogoriler J Pediatr Dev Pathol; 2019; 22(6):594-598. PubMed ID: 31335288 [TBL] [Abstract][Full Text] [Related]
13. Sclerosing Epithelioid Fibrosarcoma of the Kidney: First Reported Case in a Young Child. Kurtz JL; Tan SY; Hazard FK Pediatr Dev Pathol; 2021; 24(2):148-153. PubMed ID: 33470922 [TBL] [Abstract][Full Text] [Related]
14. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features. Mohamed M; Fisher C; Thway K Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941 [TBL] [Abstract][Full Text] [Related]
16. Expanding the spectrum of translocations in sclerosing epitheloid fibrosarcoma: A new case with EWSR1-CREB3L3 fusion. Dong F; Quade BJ; Dal Cin P; Jo VY Genes Chromosomes Cancer; 2018 Dec; 57(12):675-677. PubMed ID: 30136738 [No Abstract] [Full Text] [Related]